Time trend analyses of child pedestrian morbidity in Japan

S Nakahara1, M Ichikawa2, T Sakamoto1

  • 1Department of Emergency Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo, 173-8606, Japan.

Public Health
|December 10, 2016
PubMed

Insights

Child pedestrian injuries in Japan declined significantly, especially in younger children, during the 2000s. This trend may reflect improved traffic safety and behavioral changes.

Area of Science:

  • Public Health
  • Epidemiology
  • Traffic Safety

Background:

  • Road traffic injuries pose a significant global health challenge, particularly for child pedestrians.
  • Understanding temporal trends in child pedestrian injuries is crucial for effective prevention strategies.

Purpose of the Study:

  • To quantitatively analyze time trends of child pedestrian injuries in Japan from 1975 to 2013.
  • To examine these trends across different age groups.

Main Methods:

  • Utilized nationally aggregated police data on pedestrian injuries requiring medical treatment for children aged 0-15 years (1975-2013).
  • Applied joinpoint regression analysis by age group (0-3, 4-6, 7-9, 10-12, 13-15 years) to identify trend changes.

Main Results:

  • Preschool children (0-6 years) exhibited continuous declining injury trends, accelerating in the 2000s.
  • School-aged children (7-15 years) showed minimal change until the 1990s, with declines observed in the 2000s.
  • Younger age groups experienced steeper declines in pedestrian injuries during the 2000s.

Conclusions:

  • Declining child pedestrian injury trends in the 2000s suggest improvements in Japan's traffic environment.
  • Disparities between preschool and school-aged children may stem from age-related behavioral differences, such as altered outdoor activity levels.
Abstract

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
345
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
411
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306